Related Experiment Video
Updated: Jun 7, 2026
04:01
Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with
Seong-Min Park1, Kyung-Hee Kim1,2,3, Jong Hyuk Yoon4
1Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi, Republic of Korea.
Experimental & Molecular Medicine
|June 5, 2026
Summary
This study refines medulloblastoma classification using multi-omics data, identifying subtypes with distinct differentiation trajectories and treatment vulnerabilities. These findings pave the way for targeted therapies in medulloblastoma patients.
Area of Science:
- Oncology
- Genomics
- Proteomics
Background:
- Medulloblastoma treatment is challenged by significant tumor heterogeneity.
- Current molecular classification requires refinement for improved therapeutic strategies.
Purpose of the Study:
- To integrate multi-omic data for a refined molecular classification of medulloblastoma.
- To identify novel therapeutic vulnerabilities in distinct medulloblastoma subtypes.
Main Methods:
- Generation and integration of five omics data platforms, including proteomic data.
- Liquid chromatography and mass spectrometry-based proteome analysis.
- Integrated multi-omic characterization to reclassify medulloblastoma.
Main Results:
- Identification of seven refined medulloblastoma subtypes, including reclassification of sonic hedgehog (SHH) and group 4.
- Discovery of distinct neuronal differentiation trajectories (granular neuron and unipolar brush cell) associated with favorable outcomes in SHHβ and G4γ subtypes.
- Uncovered unique proteomic and kinomic vulnerabilities in subtypes with poor clinical outcomes, demonstrating therapeutic potential with targeted inhibitors (e.g., CDK1/2, PARP, CLK1, MET).
Conclusions:
- Proteomic signatures and neuronal differentiation trajectories can guide selective therapeutic strategies for medulloblastoma subgroups.
- Targeted therapies exploiting subtype-specific vulnerabilities offer promising treatment opportunities.
- Refined classification enables personalized treatment approaches for medulloblastoma.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...